Skip to main content
Caplight Logo









Ovira

Ovira

Private
MelbourneHealthcare & Life Scienceshttps://ovira.com

Last Round

Seed

Mar 12, 2020

Total Funding Raised

$1.01M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Ovira operates in Healthcare & Life Sciences and is based in Melbourne. Its latest recorded funding round was a Seed round in March 2020.

Ovira is a medical technology company that develops non-invasive, wearable devices for menstrual pain relief.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, D2C Brands, E-commerce, Home & Lifestyle

Business Model

B2C

Customer Profile

Hardware Sales, Subscription SaaS

AI Layer

Non-AI

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

Ovira Comparables

Compare Ovira with similar companies based on industry and business-model similarity.

Ovira comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
iPulse Medical
93%
Myoovi
90%
Juno Technologies
89%
Book a demo to see all comparables

For institutional investors. Book with your work email.

Ovira Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedMar 12, 2020
AcceleratorJul 22, 2019
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

Ovira Investors

Notable investors and investment history

Ovira investors
InvestorRounds
StartmateSeed, Accelerator
Blackbird VenturesSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 27, 2026

    Grew 50% QoQ, from 6 to 9 employees.

  • Mar 1, 2026

    Monthly visitors increased 58% MoM.

Book a demo to see all signals

For institutional investors. Book with your work email.

Ovira Filings

Explore SEC and related filing metadata, where available.

Ovira filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about Ovira's valuation, stock price, and market status.

Is Ovira a public or private company?

Ovira is a private company.

What is the current stock price of Ovira?

Ovira is a private company, so its shares have no public market price. Caplight tracks Ovira's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Ovira worth (valuation)?

Valuation information for Ovira is not publicly available.

Can I buy Ovira stock?

Ovira shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Ovira's last funding round?

Ovira's most recent funding round was Seed on March 12, 2020.

Who are the main investors in Ovira?

Key investors in Ovira include Blackbird Ventures.

Will Ovira IPO soon?

No public IPO plans have been announced for Ovira.

How can I track Ovira secondary market activity?

Caplight tracks bids, offers, and trades in Ovira's shares on secondary markets.

Firmographic Details

HeadquartersMelbourne
Employee Range2
Year Founded2018
Last FundingMar 12, 2020

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?